Stockreport

Aurinia Pharmaceuticals Inc (AUPH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com
PDF Net Product Sales of LUPKYNIS (Q4 2024): $57.6 million, up 36% from $42.3 million in Q4 2023. Net Product Sales of LUPKYNIS (Full Year 2024): $216.2 million, up 36% f [Read more]